223 related articles for article (PubMed ID: 17100847)
1. Lack of effects of GHB precursors GBL and 1,4-BD following i.c.v. administration in rats.
Carter LP; Koek W; France CP
Eur J Neurosci; 2006 Nov; 24(9):2595-600. PubMed ID: 17100847
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of equimolar doses of gamma-hydroxybutyrate (GHB), 1,4-butanediol (1,4-BD) and gamma-butyrolactone (GBL) on catalepsy after acute and chronic administration.
Towiwat P; Phattanarudee S; Maher TJ
Food Chem Toxicol; 2013 Jan; 51():337-42. PubMed ID: 23104245
[TBL] [Abstract][Full Text] [Related]
3. Gamma-Hydroxybutyrate (GHB), gamma-butyrolactone (GBL), and 1,4-butanediol (1,4-BD) reduce the volume of cerebral infarction in rodent transient middle cerebral artery occlusion.
Sadasivan S; Maher TJ; Quang LS
Ann N Y Acad Sci; 2006 Aug; 1074():537-44. PubMed ID: 17105951
[TBL] [Abstract][Full Text] [Related]
4. Cataleptic effects of gamma-hydroxybutyrate (GHB), its precursor gamma-butyrolactone (GBL), and GABAB receptor agonists in mice: differential antagonism by the GABAB receptor antagonist CGP35348.
Koek W; Mercer SL; Coop A
Psychopharmacology (Berl); 2007 Jun; 192(3):407-14. PubMed ID: 17277933
[TBL] [Abstract][Full Text] [Related]
5. Discriminative stimulus effects of flumazenil: perceptual masking by baclofen, and lack of substitution with gamma-hydroxybutyrate and its precursors 1,4-butanediol and gamma-butyrolactone.
Koek W; Carter LP; Wu H; Coop A; France CP
Behav Pharmacol; 2006 May; 17(3):239-47. PubMed ID: 16572002
[TBL] [Abstract][Full Text] [Related]
6. Gamma butyrolactone (GBL) and gamma valerolactone (GVL): similarities and differences in their effects on the acoustic startle reflex and the conditioned enhancement of startle in the rat.
Marinetti LJ; Leavell BJ; Jones CM; Hepler BR; Isenschmid DS; Commissaris RL
Pharmacol Biochem Behav; 2012 Jun; 101(4):602-8. PubMed ID: 22349589
[TBL] [Abstract][Full Text] [Related]
7. Behavioral effects and pharmacokinetics of gamma-hydroxybutyrate (GHB) precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD) in baboons.
Goodwin AK; Brown PR; Jansen EE; Jakobs C; Gibson KM; Weerts EM
Psychopharmacology (Berl); 2009 Jun; 204(3):465-76. PubMed ID: 19198808
[TBL] [Abstract][Full Text] [Related]
8. The clinical toxicology of γ-hydroxybutyrate, γ-butyrolactone and 1,4-butanediol.
Schep LJ; Knudsen K; Slaughter RJ; Vale JA; Mégarbane B
Clin Toxicol (Phila); 2012 Jul; 50(6):458-70. PubMed ID: 22746383
[TBL] [Abstract][Full Text] [Related]
9. Effects of gamma-hydroxybutyrate (GHB) on schedule-controlled responding in rats: role of GHB and GABAB receptors.
Carter LP; Wu H; Chen W; Cruz CM; Lamb RJ; Koek W; Coop A; France CP
J Pharmacol Exp Ther; 2004 Jan; 308(1):182-8. PubMed ID: 14569056
[TBL] [Abstract][Full Text] [Related]
10. Discriminative stimulus effects of gamma-hydroxybutyrate (GHB) in rats discriminating GHB from baclofen and diazepam.
Koek W; Carter LP; Lamb RJ; Chen W; Wu H; Coop A; France CP
J Pharmacol Exp Ther; 2005 Jul; 314(1):170-9. PubMed ID: 15774716
[TBL] [Abstract][Full Text] [Related]
11. The role of GABAB receptors in the discriminative stimulus effects of gamma-hydroxybutyrate in rats: time course and antagonism studies.
Carter LP; Flores LR; Wu H; Chen W; Unzeitig AW; Coop A; France CP
J Pharmacol Exp Ther; 2003 May; 305(2):668-74. PubMed ID: 12606639
[TBL] [Abstract][Full Text] [Related]
12. In vivo conversion of gamma-aminobutyric acid and 1,4-butanediol to gamma-hydroxybutyric acid in rat brain. Studies using stable isotopes.
Snead OC; Furner R; Liu CC
Biochem Pharmacol; 1989 Dec; 38(24):4375-80. PubMed ID: 2604740
[TBL] [Abstract][Full Text] [Related]
13. Influence of reinforcer type and route of administration on gamma-hydroxybutyrate discrimination in rats.
Baker LE; Pynnonen D; Poling A
Psychopharmacology (Berl); 2004 Jul; 174(2):220-7. PubMed ID: 14991222
[TBL] [Abstract][Full Text] [Related]
14. Gamma hydroxybutyrate (GHB), gamma butyrolactone (GBL) and 1,4-butanediol (1,4-BD; BDO): A literature review with a focus on UK fatalities related to non-medical use.
Corkery JM; Loi B; Claridge H; Goodair C; Corazza O; Elliott S; Schifano F
Neurosci Biobehav Rev; 2015 Jun; 53():52-78. PubMed ID: 25843781
[TBL] [Abstract][Full Text] [Related]
15. GC/MS profiling of gamma-hydroxybutyrate and precursors in various animal tissues using automatic solid-phase extraction. Preliminary investigations of its potential interest in postmortem interval determination.
Richard D; Ling B; Authier N; Faict TW; Eschalier A; Coudoré F
Anal Chem; 2005 Mar; 77(5):1354-60. PubMed ID: 15732918
[TBL] [Abstract][Full Text] [Related]
16. Chronic intragastric administration of gamma-butyrolactone produces physical dependence in baboons.
Goodwin AK; Griffiths RR; Brown PR; Froestl W; Jakobs C; Gibson KM; Weerts EM
Psychopharmacology (Berl); 2006 Nov; 189(1):71-82. PubMed ID: 17047936
[TBL] [Abstract][Full Text] [Related]
17. Behavioral effects of gamma-hydroxybutyrate, its precursor gamma-butyrolactone, and GABA(B) receptor agonists: time course and differential antagonism by the GABA(B) receptor antagonist 3-aminopropyl(diethoxymethyl)phosphinic acid (CGP35348).
Koek W; Mercer SL; Coop A; France CP
J Pharmacol Exp Ther; 2009 Sep; 330(3):876-83. PubMed ID: 19564487
[TBL] [Abstract][Full Text] [Related]
18. Differentiating the discriminative stimulus effects of gamma-hydroxybutyrate and ethanol in a three-choice drug discrimination procedure in rats.
Baker LE; Searcy GD; Pynnonen DM; Poling A
Pharmacol Biochem Behav; 2008 Jun; 89(4):598-607. PubMed ID: 18374971
[TBL] [Abstract][Full Text] [Related]
19. Experimental absence seizures: potential role of gamma-hydroxybutyric acid and GABAB receptors.
Bernasconi R; Lauber J; Marescaux C; Vergnes M; Martin P; Rubio V; Leonhardt T; Reymann N; Bittiger H
J Neural Transm Suppl; 1992; 35():155-77. PubMed ID: 1324978
[TBL] [Abstract][Full Text] [Related]
20. Gamma-butyrolactone (GBL) disruption of passive avoidance learning in the day-old chick appears to be due to its effect on GABAB not gamma-hydroxybutyric [corrected] acid (GHB) receptors.
Sherry JM; Hazi A; Hale MW; Milsome SL; Crowe SF
Behav Brain Res; 2009 Feb; 197(2):347-55. PubMed ID: 18948143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
